Skip to main content

Table 5 Clinical correlation analysis between 10 prognostic GRGs, riskscore and clinical features

From: A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma

id age gender race grade stage T M N
ANKZF1 −0.511 (0.610) 0.375 (0.708) 5.65 (0.059) −2.764 (0.006) −3.114 (0.002) −2.766 (0.006) −3.05 (0.003) −0.075 (0.940)
CD44 −0.342 (0.733) −2.495 (0.013) 4.916 (0.086) −2.216 (0.027) − 2.172 (0.031) − 2.268 (0.024) −1.832 (0.070) 0.795 (0.427)
CHST6 −1.198 (0.233) −0.024 (0.981) 5.346 (0.069) −1.743 (0.082) −1.794 (0.074) −1.872 (0.063) 0.193 (0.847) 0.581 (0.561)
HS6ST2 −0.236 (0.814) 1.4 (0.163) 1.036 (0.596) 0.206 (0.837) −0.313 (0.755) −0.593 (0.554) − 0.12 (0.905) −0.394 (0.694)
IDUA −0.556 (0.579) 1.105 (0.270) 13.523 (0.001) −4.243 (2.673e-05) −4.079 (5.649e-05) −3.349 (9.142e-04) −3.78 (2.389e-04) −0.132 (0.895)
KIF20A −0.84 (0.402) −2.636 (0.009) 16.433 (2.701e-04) −5.354 (1.566e-07) −4.874 (1.993e-06) − 4.542 (9.366e-06) − 2.609 (0.010) − 0.112 (0.911)
NDST3 −0.454 (0.650) − 0.447 (0.655) 0.183 (0.912) −2.118 (0.035) −1.423 (0.156) − 1.434 (0.153) − 1.32 (0.189) 2.511 (0.013)
PLOD2 0.171 (0.865) −2.622 (0.009) 9.262 (0.010) −2.86 (0.004) −4.439 (1.319e-05) −4.286 (2.663e-05) −2.177 (0.031) 1.353 (0.177)
VCAN −0.054 (0.957) −2.013 (0.045) 5.449 (0.066) −1.422 (0.156) −1.507 (0.133) − 1.453 (0.147) −0.316 (0.752) 0.947 (0.344)
FBP1 1.325 (0.186) 4.761 (3.75e-06) 5.32 (0.070) 3.295 (0.001) 3.412 (7.026e-04) 3.303 (0.001) 0.967 (0.335) 0.976 (0.330)
riskScore −1.338 (0.183) −1.399 (0.163) 0.705 (0.703) −2.178 (0.030) − 2.111 (0.036) − 2.048 (0.042) −0.851 (0.396) −0.655 (0.513)